1. Home
  2. MOH vs KYMR Comparison

MOH vs KYMR Comparison

Compare MOH & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molina Healthcare Inc

MOH

Molina Healthcare Inc

N/A

Current Price

$203.54

Market Cap

10.5B

Sector

Health Care

ML Signal

N/A

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$117.22

Market Cap

10.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MOH
KYMR
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
10.6B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
MOH
KYMR
Price
$203.54
$117.22
Analyst Decision
Hold
Strong Buy
Analyst Count
13
26
Target Price
$167.00
$107.72
AVG Volume (30 Days)
481.7K
649.1K
Earning Date
04-22-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.46
N/A
Revenue
$45,426,000,000.00
$39,211,000.00
Revenue This Year
$2.40
$10.61
Revenue Next Year
$5.18
$8.17
P/E Ratio
$136.14
N/A
Revenue Growth
11.75
N/A
52 Week Low
$121.06
$40.10
52 Week High
$244.89
$130.05

Technical Indicators

Market Signals
Indicator
MOH
KYMR
Relative Strength Index (RSI) 48.26 53.03
Support Level $188.66 $108.87
Resistance Level $202.83 $120.37
Average True Range (ATR) 6.18 4.70
MACD 0.41 -0.53
Stochastic Oscillator 23.51 44.61

Price Performance

Historical Comparison
MOH
KYMR

About MOH Molina Healthcare Inc

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: